Josh Blacher

Josh Blacher has over 20 years of experience as a Chief Financial Officer (CFO), specializing in optimizing fiscal health and transforming business decision-making through data-driven insights and forward-thinking. Blacher has a track record of raising profitability, high-impact issues, and transformational deal-making, including IPOs, follow-on offerings, M&A, licensing, and partnerships. He is a strategic partner to the C-suite, advising impacts of potential decisions, including wide-ranging financial transactions. He is savvy in building finance functions from the ground up, pioneering new financial models and global initiatives.

Blacher earned his Master of Business Administration (MBA) from Columbia Business School and his Bachelor of Arts (BA) from Yeshiva University. He is the Managing Partner at Columbus Circle Capital and formerly served as the Chief Business Officer at InMed Pharmaceuticals and the CFO of Therapix Biosciences Ltd. Blacher's professional experience also includes positions as a Director at Teva Pharmaceuticals, Vice President at Deutsche Asset Management, Associate at Morgan Stanley, and Analyst at Lehman Brothers.

Blacher's inborn leadership characteristics include integrity, accountability, empathy, humility, resilience, vision, influence, and positivity.